Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors
- PMID: 17988194
- DOI: 10.1089/hum.2007.099
Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors
Abstract
Sleeping Beauty (SB) DNA transposon-based vectors belong to a growing family of nonviral integrating vectors that represent attractive alternatives to conventional virus-based integrating gene vehicles. Because of concerns related to mutagenesis and/or activation of cellular genes by integrating vectors, much attention has been paid to integration site preferences and the ability of vectors to influence expression of neighboring genes. Here, we test the hypothesis that terminal repeats of transposons carry cis-acting regulatory sequences. In transient gene expression studies, we demonstrate that the inverted repeats of SB direct gene expression in HeLa cells to levels that are 3-fold higher than in promoter-deficient controls. Inverted repeats pointing toward the transposon center consistently facilitate the highest levels of activity in a number of cell lines. We show that transposon sequences flanking the inverted repeats of SB are required for positive effects on gene expression and, moreover, that these regions contain both stimulatory and inhibitory cis-acting elements. In the context of an integrated SB vector the regulatory activities of the transposon termini are sufficient to drive expression of selectable marker genes carried by the transposon, indicating that opposing transcriptional activities originating from the transposon termini may influence expression of its genetic cargo. Finally, detection of regulatory properties of the terminal repeats of the active Tc3 element from Caenorhabditis elegans leads to the suggestion that transcriptional activities of the inverted repeats are conserved among Tc1/mariner transposons in nature. Our data suggest that SB-based gene vectors may carry ancient properties of self-regulation with potential relevance for SB-directed therapeutic gene transfer.
Similar articles
-
Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates.J Mol Biol. 2000 Sep 8;302(1):93-102. doi: 10.1006/jmbi.2000.4047. J Mol Biol. 2000. PMID: 10964563
-
Development of hyperactive sleeping beauty transposon vectors by mutational analysis.Mol Ther. 2004 Feb;9(2):292-304. doi: 10.1016/j.ymthe.2003.11.024. Mol Ther. 2004. PMID: 14759813
-
Sleeping beauty transposon-mediated gene therapy for prolonged expression.Adv Genet. 2005;54:189-232. doi: 10.1016/S0065-2660(05)54009-4. Adv Genet. 2005. PMID: 16096013 Review.
-
Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.Mol Ther. 2004 Aug;10(2):260-8. doi: 10.1016/j.ymthe.2004.05.005. Mol Ther. 2004. PMID: 15294173
-
The Sleeping Beauty transposon toolbox.Methods Mol Biol. 2012;859:229-40. doi: 10.1007/978-1-61779-603-6_13. Methods Mol Biol. 2012. PMID: 22367875 Review.
Cited by
-
DNA transposon-based gene vehicles - scenes from an evolutionary drive.J Biomed Sci. 2013 Dec 9;20(1):92. doi: 10.1186/1423-0127-20-92. J Biomed Sci. 2013. PMID: 24320156 Free PMC article. Review.
-
Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy.ISRN Oncol. 2012;2012:616310. doi: 10.5402/2012/616310. Epub 2012 Nov 22. ISRN Oncol. 2012. PMID: 23209944 Free PMC article.
-
RNA interference is responsible for reduction of transgene expression after Sleeping Beauty transposase mediated somatic integration.PLoS One. 2012;7(5):e35389. doi: 10.1371/journal.pone.0035389. Epub 2012 May 3. PLoS One. 2012. PMID: 22570690 Free PMC article.
-
Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.Bioessays. 2010 Sep;32(9):756-67. doi: 10.1002/bies.201000027. Bioessays. 2010. PMID: 20652893 Free PMC article. Review.
-
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.Gene Ther. 2021 Sep;28(9):560-571. doi: 10.1038/s41434-021-00254-w. Epub 2021 Apr 13. Gene Ther. 2021. PMID: 33846552 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical